Introducing the T1GER study.
A clinical research study for people ages 6–21 who are newly diagnosed with type 1 diabetes.

This clinical research study is being conducted to determine the safety and efficacy of an investigational medication in children and young adults newly diagnosed with type 1 diabetes.

Each patient will be evaluated to determine his or her eligibility to participate in the study. Those who qualify will receive the investigational medication or a placebo, along with study-related medical exams and laboratory tests, at no cost. Compensation may also be available to assist with travel expenses. Learn more about the T1GER study.

Find a participating site

Find a participating site.

To find a research site, and to see if you or your child may qualify, enter your zip code below or click on the map to find the participating research site(s) nearest you.

View full list of locations by state. »

Active Site   Active Site Location   Future Site   Future Site Location

Legal Policy

Privacy Policy

The image depicted contains models and is being used for illustrative purposes only.

© Janssen Research & Development, LLC 2017. This site is published by Praxis Communications, LLC on behalf of Janssen Research & Development, LLC, who is solely responsible for its content.
Its contents are intended for residents of the United States only. Last update: 03March2017